Nuvalent prices $500M public offering at $101/share; net proceeds ~$472M

Nuvalent, Inc.

Pricing of 4,950,496 shares at $101.00/share for gross proceeds of ~$500M.
Net proceeds to Nuvalent of ~$471.9M after underwriting discounts and expenses.
Selling stockholders (Deerfield funds) have 30-day option to sell 742,574 additional shares; Nuvalent receives no proceeds.
Closing expected on November 20, 2025; net proceeds plus existing cash expected to fund operations into 2029.
Joint book-running managers: J.P. Morgan, Jefferies, TD Cowen, and Cantor.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.